RIGL EBITDA | RIGEL PHARMACEUTICALS, INC.

RIGEL PHARMACEUTICALS, INC. (RIGL) EBITDA

2026-06-30: Basis Reported; EBITDA $24.42M*; Operating income $23.57M; Depreciation and amortization $848.00K*.
2026-03-31: Basis Reported; EBITDA $12.48M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA $23.77M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA $29.02M*; Operating income $28.42M; Depreciation and amortization $603.00K*.

Complete source-backed ebitda history.

Available history: 2009-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$24.42M*	$23.57M	$848.00K*	$78.70M	31.03%*	(m)	$30.65M*	$8.53M	$13.96M	$32.64M	$6.29M
2026-03-31	Reported	$12.48M	(m)	(m)	(m)	21.22%	(m)	$2.73M	$4.61M	$11.68M	$30.65M	$3.00M
2025-12-31	Reported	$23.77M	(m)	(m)	(m)	34.05%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	$29.02M*	$28.42M	$603.00K*	$69.46M	41.78%*	(m)	$24.03M*	$4.75M	(m)	$28.94M	-$280.00K
2025-06-30	Reported	$61.71M*	$61.10M	$607.00K*	$101.69M	60.69%*	(m)	$30.54M*	$4.50M	$6.82M	$29.26M	$369.00K
2025-03-31	Reported	$13.38M	(m)	(m)	(m)	25.08%	(m)	-$893.00K	$4.41M	$8.44M	$27.71M	$65.00K
2024-12-31	Reported	$17.26M	(m)	(m)	(m)	29.97%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	$14.67M*	$14.06M	$611.00K*	$55.31M	26.52%*	(m)	$21.68M*	$8.03M	(m)	$27.04M	$0.00
2024-06-30	Reported	$1.06M*	$447.00K	$613.00K*	$36.84M	2.88%*	(m)	$302.00K*	$2.81M	(m)	$28.05M	$0.00
2024-03-31	Reported	-$6.57M	(m)	(m)	(m)	-22.23%	(m)	-$5.01M	$2.02M	(m)	$28.45M	$0.00
2023-12-31	Reported	$2.26M	(m)	(m)	(m)	6.31%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	-$4.17M*	-$4.46M	$292.00K*	$28.13M	-14.83%*	(m)	-$1.36M*	$1.27M	(m)	$24.86M	(m)
2023-06-30	Reported	-$4.97M*	-$5.27M	$296.00K*	$26.89M	-18.49%*	(m)	$5.93M*	$1.07M	(m)	$26.31M	(m)
2023-03-31	Reported	-$12.37M	(m)	(m)	(m)	-47.44%	(m)	-$4.07M	$977.00K	(m)	$27.73M	(m)
2022-12-31	Reported	$2.36M	(m)	(m)	(m)	4.61%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$18.16M*	-$18.40M	$240.00K*	$22.41M	-81.05%*	$189.00K*	-$13.30M*	$250.00K	(m)	$25.90M	$0.00
2022-06-30	Reported	-$12.73M*	-$12.96M	$237.00K*	$29.82M	-42.68%*	-$36.00K*	-$12.91M*	$1.04M	(m)	$26.98M	$0.00
2022-03-31	Reported	-$26.02M	(m)	(m)	(m)	-155.51%	$224.00K	-$25.64M	$121.00K	(m)	$27.40M	$0.00
2021-12-31	Reported	-$21.01M	(m)	(m)	(m)	-102.96%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	-$19.52M*	-$19.79M	$261.00K*	$21.54M	-90.63%*	$170.00K*	-$10.30M*	$151.00K	(m)	$22.88M	-$136.00K
2021-06-30	Reported	-$12.79M*	-$13.05M	$258.00K*	$26.27M	-48.69%*	$407.00K*	$55.22M*	$129.00K	(m)	$22.38M	-$970.00K
2021-03-31	Reported	$41.99M	(m)	(m)	(m)	51.83%	$71.00K	-$19.95M	$316.00K	(m)	$22.12M	$1.77M
2020-12-31	Reported	-$18.62M	(m)	(m)	(m)	-100.93%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	-$13.62M*	-$13.78M	$165.00K*	$18.39M	-74.04%*	$195.00K*	-$19.48M*	$140.00K	(m)	$17.43M	$0.00
2020-06-30	Reported	-$17.23M*	-$17.39M	$164.00K*	$16.02M	-107.53%*	-$44.00K*	-$14.04M*	$279.00K	(m)	$18.92M	$0.00
2020-03-31	Reported	$21.2M	(m)	(m)	(m)	38.02%	$607.00K	-$3.09M	$155.00K	(m)	$18.43M	$0.00
2019-12-31	Reported	-$17.16M	(m)	(m)	(m)	-111.41%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	-$11.87M*	-$12.04M	$166.00K*	$20.86M	-56.92%*	$352.00K*	-$14.64M*	$310.00K	(m)	$18.12M	(m)
2019-06-30	Reported	-$21.17M*	-$21.34M	$173.00K*	$10.41M	-203.38%*	$115.00K*	-$16.65M*	$311.00K	(m)	$18.21M	(m)
2019-03-31	Reported	-$18.21M	(m)	(m)	(m)	-144.28%	$377.00K	-$569.00K	$107.00K	(m)	$19.95M	(m)
2018-12-31	Reported	$2.7M	(m)	(m)	(m)	7.12%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	-$24.21M*	-$24.37M	$159.00K*	$4.87M	-497.66%*	$156.00K*	-$20.08M*	$69.00K	(m)	$18.07M	(m)
2018-06-30	Reported	-$25.95M*	-$26.11M	$159.00K*	$1.79M	-1452.27%*	$684.00K*	-$26.99M*	$30.00K	(m)	$17.07M	(m)
2018-03-31	Reported	-$24.62M	(m)	(m)	(m)	(m)	$197.00K	-$23.39M	(m)	(m)	$13.49M	(m)
2017-12-31	Reported	-$26.1M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	-$17.74M*	-$17.86M	$112.00K*	$900.00K	-1971.44%*	$56.00K*	-$17.61M*	(m)	(m)	(m)	(m)
2017-06-30	Reported	-$19.23M*	-$19.34M	$114.00K*	(m)	(m)	$14.00K*	-$19.47M*	(m)	(m)	(m)	(m)
2017-03-31	Reported	-$16.08M	(m)	(m)	(m)	(m)	$41.00K	-$20.76M	(m)	(m)	(m)	(m)
2016-12-31	Reported	-$15.64M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	-$22.52M*	-$22.74M	$214.00K*	(m)	(m)	$252.00K*	-$22.57M*	(m)	(m)	(m)	(m)
2016-06-30	Reported	-$13.39M*	-$13.65M	$260.00K*	(m)	(m)	$225.00K*	(m)	(m)	(m)	(m)	(m)
2016-03-31	Reported	-$17.24M	(m)	(m)	(m)	(m)	$321.00K	(m)	(m)	(m)	(m)	(m)
2015-12-31	Reported	-$12.41M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$6.49M*	-$6.78M	$287.00K*	(m)	(m)	$307.00K*	(m)	(m)	(m)	(m)	(m)
2015-06-30	Reported	-$13.60M*	-$13.97M	$379.00K*	(m)	(m)	$73.00K*	(m)	(m)	(m)	(m)	(m)
2015-03-31	Reported	-$17.81M	(m)	(m)	(m)	(m)	$32.00K	(m)	(m)	(m)	(m)	(m)
2014-12-31	Reported	-$21.86M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$20.47M*	-$21.04M	$574.00K*	(m)	(m)	-$40.00K*	(m)	(m)	(m)	(m)	(m)
2014-06-30	Reported	-$24.83M*	-$25.46M	$623.00K*	(m)	(m)	$75.00K*	(m)	(m)	(m)	(m)	(m)
2014-03-31	Reported	-$21.73M	(m)	(m)	(m)	(m)	$178.00K	(m)	(m)	(m)	(m)	(m)
2013-12-31	Reported	-$16.29M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$23.29M*	-$23.93M	$644.00K*	(m)	(m)	$128.00K*	(m)	(m)	(m)	(m)	(m)
2013-06-30	Reported	-$22.26M*	-$22.89M	$628.00K*	(m)	(m)	$249.00K*	(m)	(m)	(m)	(m)	(m)
2013-03-31	Reported	-$25.04M	(m)	(m)	(m)	(m)	$676.00K	(m)	(m)	(m)	(m)	(m)
2012-12-31	Reported	-$24.98M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	-$24.93M*	-$25.57M	$635.00K*	(m)	(m)	$384.00K*	(m)	(m)	(m)	(m)	(m)
2012-06-30	Reported	-$24.27M*	-$24.88M	$610.00K*	(m)	(m)	$818.00K*	(m)	(m)	(m)	(m)	(m)
2012-03-31	Reported	-$22.76M	(m)	(m)	(m)	(m)	$1.57M	(m)	(m)	(m)	(m)	(m)
2011-12-31	Reported	-$25.38M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	-$17.54M*	-$18.04M	$506.00K*	(m)	(m)	$561.00K*	(m)	(m)	(m)	(m)	(m)
2011-06-30	Reported	-$21.08M*	-$21.56M	$476.00K*	(m)	(m)	$697.00K*	(m)	(m)	$17.11M	(m)	(m)
2011-03-31	Reported	-$20.41M	(m)	(m)	(m)	(m)	$860.00K	(m)	(m)	(m)	(m)	(m)
2010-12-31	Reported	-$19.28M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-30	Reported	$50.69M*	$50.36M	$327.00K*	(m)	(m)	$897.00K*	(m)	(m)	(m)	(m)	(m)
2010-06-30	Reported	(m)	$26.98M	(m)	(m)	(m)	(m)	(m)	(m)	$16.82M	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	$127.88M	(m)	(m)	(m)	43.46%	(m)	$75.66M	$19.62M	$33.30M	$115.90M	-$245.20M
2024-12-31	Reported	$26.42M	(m)	(m)	(m)	14.74%	(m)	$31.47M	$18.65M	$23.38M	$113.06M	$881.00K
2023-12-31	Reported	-$19.25M	(m)	(m)	(m)	-16.47%	(m)	-$5.74M	$7.11M	$24.52M	$105.74M	$0.00
2022-12-31	Reported	-$54.55M	(m)	(m)	(m)	-45.37%	$450.00K	-$73.76M	$1.75M	(m)	$112.45M	(m)
2021-12-31	Reported	-$11.33M	(m)	(m)	(m)	-7.59%	$627.00K	$5.88M	$1.08M	(m)	$91.89M	$605.00K
2020-12-31	Reported	-$28.27M	(m)	(m)	(m)	-26.02%	$1.26M	-$52.19M	$895.00K	(m)	$76.60M	(m)
2019-12-31	Reported	-$68.41M	(m)	(m)	(m)	-115.38%	$1.46M	-$41.51M	$906.00K	(m)	$74.59M	(m)
2018-12-31	Reported	-$72.09M	(m)	(m)	(m)	-161.96%	$1.11M	-$58.83M	$287.00K	(m)	$70.00M	$0.00
2017-12-31	Reported	-$79.15M	(m)	(m)	(m)	-1765.19%	$164.00K	-$77.56M	(m)	(m)	$37.83M	$0.00
2016-12-31	Reported	-$68.8M	(m)	(m)	(m)	-337.54%	$804.00K	-$75.89M	(m)	(m)	$20.91M	$0.00
2015-12-31	Reported	-$50.3M	(m)	(m)	(m)	(m)	$546.00K	-$23.41M	(m)	(m)	(m)	$0.00
2014-12-31	Reported	-$88.89M	(m)	(m)	(m)	(m)	$413.00K	(m)	(m)	(m)	(m)	$0.00
2013-12-31	Reported	-$86.88M	(m)	(m)	(m)	(m)	$1.22M	(m)	(m)	(m)	(m)	$0.00
2012-12-31	Reported	-$96.94M	(m)	(m)	(m)	(m)	$3.38M	(m)	(m)	(m)	(m)	(m)
2011-12-31	Reported	-$84.41M	(m)	(m)	(m)	(m)	$2.30M	(m)	(m)	(m)	(m)	(m)
2010-12-31	Reported	$36.63M	(m)	(m)	(m)	(m)	$3.56M	(m)	(m)	(m)	(m)	(m)
2009-12-31	Reported	-$110.63M	(m)	(m)	(m)	(m)	$141.00K	(m)	(m)	(m)	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Apnimed, Inc. (APMD)	United States	$0.899B
Theravance Biopharma, Inc. (TBPH)		$0.885B	16.40
Cryoport, Inc. (CYRX)	United States	$0.881B	-21.29
ARDELYX, INC. (ARDX)	United States	$0.857B	-22.86
Jade Biosciences, Inc. (JBIO)	United States	$0.936B	-9.21
Avalo Therapeutics, Inc. (AVTX)	United States	$0.842B	-9.74
Immix Biopharma, Inc. (IMMX)	United States	$0.837B	-18.44
Obsidian Therapeutics, Inc. (OBX)	United States	$0.829B
LEXICON PHARMACEUTICALS, INC. (LXRX)	United States	$0.823B	-17.48
Arbutus Biopharma Corp (ABUS)		$0.965B	6.19